CD8A and cancer: CD8+ T cells are also called cytotoxic lymphocytes (CTLs), which exert potent antitumor effects by recognizing neoantigens expressed by cancer cells or presented by antigen-presenting cells, subsequently initiating cytokine secretion or releasing granzyme B and perforin to mediate targeted cancer-cell eradication [163].